This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $71,118.73 firm fixed-price delivery order is for the supply of 4,566,612,809 units of the medication Deferasirox 360 mg tablets, with a period of performance through December 5, 2024.
The award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract encompasses critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract did not utilize any set-aside designations, indicating open competition.
Generated 3/9/25, 12:58 AM